http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445058-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fdcb29d5239b3aa63ef3b9e8f3951ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_394a48d901d5b74890f6fe2a59e43c94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa2865acfcea22c3d6e580c057071e05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61G10-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7750068871f0d010951c91aae5d3ba73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45494031945d884b332e654dc1c4dbd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43d82716072aff82f03198181d5490ae |
| publicationDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2445058-C1 |
| titleOfInvention | Method of treating inflammatory diseases of internal female genital organs |
| abstract | FIELD: medicine. n SUBSTANCE: claimed invention relates to medicine, namely, to gynecology, and can be applied for treatment of patients with inflammatory diseases of internal female genital organs. For this purpose conventional drug therapy and sessions of hyperbaric oxygenation (HBO) are carried out. Starting from the first day of treatment, against the background of drug therapy one time per day every day carried out are 6-8 sessions of HBO. First 3-4 sessions of HBO are carried out with duration 40-50 minutes each, with pressure in pressure chamber 1.1-1.3 atm. Following sessions of HBO are carried out for 35-45 minutes each with pressure in pressure chamber 1.4-1.6 atm. From the second day of treatment to patient additionally daily after sessions of HBO during 8-10 days intravenously by drip infusion introduced are 10 ml of medication cytoflavin in solution per 200 ml of 5% glucose solution. Rate of cytoflavin introduction on first 3 days constitutes 120 drops per minute. On remaining 5-7 days cytoflavin is introduced at rate 60 drops per minute. Conventional drug therapy is continued during 6 days after finishing the last session of HBO. n EFFECT: method makes it possible to essentially reduce treatment terms, as well as quantity of complications and side effects. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2557957-C1 |
| priorityDate | 2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.